Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation
Diagnosed in additional than 90% of cervical cancers, the fourth deadliest most cancers in ladies, human papillomavirus (HPV) is at the moment the commonest pathogen accountable for feminine cancers. Moreover, HPV an infection is related to many different ailments, together with cutaneous and anogenital warts, and genital and higher aerodigestive tract cancers. The incidence and prevalence of these pathologies fluctuate significantly relying on components together with HPV genotype, regional situations, the research inhabitants, and the anatomical web site sampled. Recently, options of the cervicovaginal microbiota are discovered to be related to the incidence of HPV-related ailments, presenting a novel method to establish high-risk ladies by way of each blood and cervical samples.
Overall, the HPV repartition information present that HPV an infection and associated ailments are extra prevalent in creating nations. Moreover, the out there (2-, 4-, and 9-valent) vaccines based mostly on virus-like particles, regardless of their confirmed effectiveness and security, current some limitations in phrases of system improvement price, transport chilly chain, and oncogenic HPV variants. In addition, vaccination applications face some challenges, resulting in a substantial burden of HPV an infection and associated ailments. Therefore, although the new (9-valent) vaccine appears promising, next-generation vaccines in addition to consciousness applications related to HPV vaccination and price range reinforcements for immunization are wanted.
Clinical traits and tumors of 119 NSND with HNSCC have been retrospectively collected and analyzed on tissue microarrays. RNAscope in situ hybridization (ISH) was used to display for the presence of HPV and MCPyV mRNA. Immunohistochemistry was carried out for expression of p16 as surrogate marker for HPV, Large T-antigen for MCPyV, and cell cycle proteins p53 and pRb. Positive virus outcomes have been confirmed with polymerase chain response. For EBV, EBV encoded RNA ISH was carried out. Differences in 5-year survival between virus constructive and detrimental tumors have been decided by log rank evaluation.
Split-type electrochemiluminescent gene assay platform based mostly on gold nanocluster probe for human papillomavirus prognosis
Persistent high-risk human papillomavirus (HPV) an infection is the main trigger of cervical most cancers. Efficient detection of HPV16 E7 is critical for early prognosis and remedy of the illness. Here, a novel and high-performance Au nanocluster (AuNC) probe-based split-type electrochemiluminescent (ECL) assay platform has been established to detect these oncogenes, during which the nucleic acid hybridization assay and the ECL measurements are carried out independently. The proposed method combines superior magnetic nanobead enrichment and separation know-how, particular nucleic acid hybridization know-how, and high-efficiency AuNC probe ECL technique, and reveals wonderful benefits.
Human papillomavirus antibody(IgM) Elisa Kit |
EK714259 |
AFG Bioscience LLC |
96 Wells |
EUR 0.44 |
Human papillomavirus antibody(IgM) ELISA Kit |
EK0267 |
SAB |
96 tests |
EUR 789 |
|
Human papillomavirus antibody(IgM) ELISA Kit |
CSB-E08783h-24T |
Cusabio |
1 plate of 24 wells |
EUR 198 |
|
Description: Quantitative sandwich ELISA kit for measuring Human papillomavirus antibody (IgM) in samples from serum, plasma, cell culture supernates, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
Human papillomavirus antibody(IgM) ELISA Kit |
1-CSB-E08783h |
Cusabio |
-
Ask for price
-
Ask for price
-
Ask for price
|
- 1 plate of 96 wells
- 10 plates of 96 wells each
- 5 plates of 96 wells each
|
|
Description: Quantitative sandwich ELISA kit for measuring Human papillomavirus antibody(IgM) in samples from serum, plasma, cell culture supernates, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
Human Papillomavirus 18 Antibody (Anti-HPV-18) ELISA Kit |
abx055803-100g |
Abbexa |
100 µg |
Ask for price |
Human Papillomavirus 18 Antibody (Anti-HPV-18) ELISA Kit |
abx055803-10g |
Abbexa |
10 µg |
EUR 493.75 |
Human Papillomavirus 18 Antibody (Anti-HPV-18) ELISA Kit |
abx055803-50g |
Abbexa |
50 µg |
Ask for price |
ELISA kit for Human papillomavirus antibody (IgG) |
EK0266 |
SAB |
96 tests |
EUR 854.4 |
Description: Enzyme-linked immunosorbent assay kit for quantification of Human papillomavirus antibody (IgG) in samples from serum, plasma, tissue homogenates and other biological fluids. |
Human Papillomavirus 16 (HPV-16) Antibody |
abx021894-400l |
Abbexa |
400 µl |
Ask for price |
Human Papillomavirus 16 (HPV-16) Antibody |
abx021894-80l |
Abbexa |
80 µl |
EUR 737.5 |
Human Papillomavirus 16 (HPV-16) Antibody |
abx021895-400l |
Abbexa |
400 µl |
Ask for price |
Human Papillomavirus 16 (HPV-16) Antibody |
abx021895-80l |
Abbexa |
80 µl |
EUR 700 |
Human Papillomavirus 16 (HPV16)(HPV16/1058) Antibody |
BNC811058-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(HPV16/1058), CF680R conjugate, Concentration: 0.1mg/mL |
Human Papillomavirus 16 (HPV16)(HPV16/1058) Antibody |
BNC811058-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(HPV16/1058), CF680R conjugate, Concentration: 0.1mg/mL |
Human Papillomavirus 16 (HPV16)(HPV16/1058) Antibody |
BNC801058-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(HPV16/1058), CF680 conjugate, Concentration: 0.1mg/mL |
Human Papillomavirus 16 (HPV16)(HPV16/1058) Antibody |
BNC801058-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(HPV16/1058), CF680 conjugate, Concentration: 0.1mg/mL |
Human Papillomavirus 16 (HPV16)(HPV16/1058) Antibody |
BNC431058-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(HPV16/1058), CF543 conjugate, Concentration: 0.1mg/mL |
Human Papillomavirus 16 (HPV16)(HPV16/1058) Antibody |
BNC431058-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(HPV16/1058), CF543 conjugate, Concentration: 0.1mg/mL |
Human Papillomavirus 16 (HPV16)(HPV16/1058) Antibody |
BNC051058-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(HPV16/1058), CF405M conjugate, Concentration: 0.1mg/mL |
Human Papillomavirus 16 (HPV16)(HPV16/1058) Antibody |
BNC051058-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(HPV16/1058), CF405M conjugate, Concentration: 0.1mg/mL |
Human Papillomavirus 16 (HPV16)(HPV16/1058) Antibody |
BNC551058-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(HPV16/1058), CF555 conjugate, Concentration: 0.1mg/mL |
Human Papillomavirus 16 (HPV16)(HPV16/1058) Antibody |
BNC551058-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(HPV16/1058), CF555 conjugate, Concentration: 0.1mg/mL |
Human Papillomavirus 16 (HPV16)(HPV16/1058) Antibody |
BNC701058-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(HPV16/1058), CF770 conjugate, Concentration: 0.1mg/mL |
Human Papillomavirus 16 (HPV16)(HPV16/1058) Antibody |
BNC701058-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(HPV16/1058), CF770 conjugate, Concentration: 0.1mg/mL |
Human Papillomavirus 16 (HPV16)(HPV16/1058) Antibody |
BNC611058-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(HPV16/1058), CF660R conjugate, Concentration: 0.1mg/mL |
Human Papillomavirus 16 (HPV16)(HPV16/1058) Antibody |
BNC611058-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(HPV16/1058), CF660R conjugate, Concentration: 0.1mg/mL |
Human Papillomavirus 16 (HPV16)(HPV16/1058) Antibody |
BNCP1058-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(HPV16/1058), PerCP conjugate, Concentration: 0.1mg/mL |
Human Papillomavirus 16 (HPV16)(HPV16/1058) Antibody |
BNCR1058-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(HPV16/1058), RPE conjugate, Concentration: 0.1mg/mL |
Human Papillomavirus 16 (HPV16)(HPV16/1058) Antibody |
BNCA1058-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(HPV16/1058), APC conjugate, Concentration: 0.1mg/mL |
Human Papillomavirus 16 (HPV16)(HPV16/1058) Antibody |
BNCH1058-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(HPV16/1058), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Human Papillomavirus 16 (HPV16)(HPV16/1058) Antibody |
BNCH1058-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(HPV16/1058), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Human Papillomavirus 16 (HPV16)(HPV16/1058) Antibody |
BNCAP1058-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(HPV16/1058), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Human Papillomavirus 16 (HPV16)(HPV16/1058) Antibody |
BNCAP1058-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(HPV16/1058), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Human Papillomavirus 16 L1 (HPV-16 L1) Antibody |
abx021897-400l |
Abbexa |
400 µl |
Ask for price |
Human Papillomavirus 16 L1 (HPV-16 L1) Antibody |
abx021897-80l |
Abbexa |
80 µl |
EUR 762.5 |
Human Papillomavirus 16 L1 (HPV-16 L1) Antibody |
abx021898-400l |
Abbexa |
400 µl |
Ask for price |
Human Papillomavirus 16 L1 (HPV-16 L1) Antibody |
abx021898-80l |
Abbexa |
80 µl |
EUR 800 |
Human papillomavirus |
PCR-H454-PCRH45448D |
Bioingentech |
PCR-H454-48D |
EUR 230 |
Human papillomavirus |
PCR-H454-PCRH45496D |
Bioingentech |
PCR-H454-96D |
EUR 312 |
Human papillomavirus |
Oneq-H454-OneqH454100D |
Bioingentech |
Oneq-H454-100D |
EUR 515 |
Human papillomavirus |
Oneq-H454-OneqH454150D |
Bioingentech |
Oneq-H454-150D |
EUR 594 |
Human papillomavirus |
Oneq-H454-OneqH45450D |
Bioingentech |
Oneq-H454-50D |
EUR 413 |
Human papillomavirus 6 antibody IgG (HPV6-IgG)ELISA Kit |
SL2795Hu |
Sunlong |
96 Tests |
EUR 468 |
|
Mouse Human papillomavirus(HPV) ELISA Kit |
NSL1497m |
Sunlong |
96 Test |
EUR 528 |
|
ELISA kit for Human Papillomavirus L1 antibody (HPV-L1 Ab) |
KTE62897-48T |
Abbkine |
48T |
EUR 424.8 |
Description: Quantitative sandwich ELISA for measuring Human Papillomavirus L1 antibody (HPV-L1 Ab) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
ELISA kit for Human Papillomavirus L1 antibody (HPV-L1 Ab) |
KTE62897-5platesof96wells |
Abbkine |
5 plates of 96 wells |
EUR 2702.4 |
Description: Quantitative sandwich ELISA for measuring Human Papillomavirus L1 antibody (HPV-L1 Ab) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
ELISA kit for Human Papillomavirus L1 antibody (HPV-L1 Ab) |
KTE62897-96T |
Abbkine |
96T |
EUR 686.4 |
Description: Quantitative sandwich ELISA for measuring Human Papillomavirus L1 antibody (HPV-L1 Ab) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
Human Papillomavirus 16 (HPV16)(CAMVIR-1) Antibody |
BNC810502-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(CAMVIR-1), CF680R conjugate, Concentration: 0.1mg/mL |
Human Papillomavirus 16 (HPV16)(CAMVIR-1) Antibody |
BNC810502-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(CAMVIR-1), CF680R conjugate, Concentration: 0.1mg/mL |
Human Papillomavirus 16 (HPV16)(CAMVIR-1) Antibody |
BNC430502-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(CAMVIR-1), CF543 conjugate, Concentration: 0.1mg/mL |
Human Papillomavirus 16 (HPV16)(CAMVIR-1) Antibody |
BNC430502-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(CAMVIR-1), CF543 conjugate, Concentration: 0.1mg/mL |
Human Papillomavirus 16 (HPV16)(CAMVIR-1) Antibody |
BNC050502-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(CAMVIR-1), CF405M conjugate, Concentration: 0.1mg/mL |
Human Papillomavirus 16 (HPV16)(CAMVIR-1) Antibody |
BNC050502-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(CAMVIR-1), CF405M conjugate, Concentration: 0.1mg/mL |
Human Papillomavirus 16 (HPV16)(CAMVIR-1) Antibody |
BNC550502-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(CAMVIR-1), CF555 conjugate, Concentration: 0.1mg/mL |
Human Papillomavirus 16 (HPV16)(CAMVIR-1) Antibody |
BNC550502-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(CAMVIR-1), CF555 conjugate, Concentration: 0.1mg/mL |
Human Papillomavirus 16 (HPV16)(CAMVIR-1) Antibody |
BNC800502-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(CAMVIR-1), CF680 conjugate, Concentration: 0.1mg/mL |
Human Papillomavirus 16 (HPV16)(CAMVIR-1) Antibody |
BNC800502-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(CAMVIR-1), CF680 conjugate, Concentration: 0.1mg/mL |
Human Papillomavirus 16 (HPV16)(CAMVIR-1) Antibody |
BNC610502-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(CAMVIR-1), CF660R conjugate, Concentration: 0.1mg/mL |
Human Papillomavirus 16 (HPV16)(CAMVIR-1) Antibody |
BNC610502-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(CAMVIR-1), CF660R conjugate, Concentration: 0.1mg/mL |
Human Papillomavirus 16 (HPV16)(CAMVIR-1) Antibody |
BNC700502-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(CAMVIR-1), CF770 conjugate, Concentration: 0.1mg/mL |
Human Papillomavirus 16 (HPV16)(CAMVIR-1) Antibody |
BNC700502-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(CAMVIR-1), CF770 conjugate, Concentration: 0.1mg/mL |
Human Papillomavirus 16 (HPV16)(CAMVIR-1) Antibody |
BNCP0502-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(CAMVIR-1), PerCP conjugate, Concentration: 0.1mg/mL |
Human Papillomavirus 16 (HPV16)(CAMVIR-1) Antibody |
BNCR0502-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(CAMVIR-1), RPE conjugate, Concentration: 0.1mg/mL |
Human Papillomavirus 16 (HPV16)(CAMVIR-1) Antibody |
BNCA0502-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(CAMVIR-1), APC conjugate, Concentration: 0.1mg/mL |
Human Papillomavirus 16 (HPV16)(CAMVIR-1) Antibody |
BNCAP0502-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(CAMVIR-1), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Human Papillomavirus 16 (HPV16)(CAMVIR-1) Antibody |
BNCAP0502-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(CAMVIR-1), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Human Papillomavirus 16 (HPV16)(CAMVIR-1) Antibody |
BNCH0502-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(CAMVIR-1), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Human Papillomavirus 16 (HPV16)(CAMVIR-1) Antibody |
BNCH0502-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(CAMVIR-1), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Human papillomavirus 18 antibody IgG (HPV18-IgG)ELISA Kit |
SL2639Hu |
Sunlong |
96 Tests |
EUR 468 |
|
Human papillomavirus 11 antibody IgG (HPV11-IgG) ELISA Kit |
SL3132Hu |
Sunlong |
96 Tests |
EUR 468 |
|
Human papillomavirus 6 |
PCR-H461-PCRH46148D |
Bioingentech |
PCR-H461-48D |
EUR 230 |
Human papillomavirus 6 |
PCR-H461-PCRH46196D |
Bioingentech |
PCR-H461-96D |
EUR 312 |
Human papillomavirus 11 |
PCR-H462-PCRH46248D |
Bioingentech |
PCR-H462-48D |
EUR 230 |
Human papillomavirus 11 |
PCR-H462-PCRH46296D |
Bioingentech |
PCR-H462-96D |
EUR 312 |
Human papillomavirus 16 |
PCR-H463-PCRH46348D |
Bioingentech |
PCR-H463-48D |
EUR 230 |
Human papillomavirus 16 |
PCR-H463-PCRH46396D |
Bioingentech |
PCR-H463-96D |
EUR 312 |
Human papillomavirus 18 |
PCR-H464-PCRH46448D |
Bioingentech |
PCR-H464-48D |
EUR 230 |
Human papillomavirus 18 |
PCR-H464-PCRH46496D |
Bioingentech |
PCR-H464-96D |
EUR 312 |
Human papillomavirus 30 |
PCR-H465-PCRH46548D |
Bioingentech |
PCR-H465-48D |
EUR 230 |
Human papillomavirus 30 |
PCR-H465-PCRH46596D |
Bioingentech |
PCR-H465-96D |
EUR 312 |
Human papillomavirus 31 |
PCR-H466-PCRH46648D |
Bioingentech |
PCR-H466-48D |
EUR 230 |
Human papillomavirus 31 |
PCR-H466-PCRH46696D |
Bioingentech |
PCR-H466-96D |
EUR 312 |
Human papillomavirus 33 |
PCR-H467-PCRH46748D |
Bioingentech |
PCR-H467-48D |
EUR 230 |
Human papillomavirus 33 |
PCR-H467-PCRH46796D |
Bioingentech |
PCR-H467-96D |
EUR 312 |
Human papillomavirus 35 |
PCR-H468-PCRH46848D |
Bioingentech |
PCR-H468-48D |
EUR 230 |
Human papillomavirus 35 |
PCR-H468-PCRH46896D |
Bioingentech |
PCR-H468-96D |
EUR 312 |
Human papillomavirus 39 |
PCR-H469-PCRH46948D |
Bioingentech |
PCR-H469-48D |
EUR 230 |
Human papillomavirus 39 |
PCR-H469-PCRH46996D |
Bioingentech |
PCR-H469-96D |
EUR 312 |
Human papillomavirus 40 |
PCR-H470-PCRH47048D |
Bioingentech |
PCR-H470-48D |
EUR 230 |
Human papillomavirus 40 |
PCR-H470-PCRH47096D |
Bioingentech |
PCR-H470-96D |
EUR 312 |
Human papillomavirus 42 |
PCR-H471-PCRH47148D |
Bioingentech |
PCR-H471-48D |
EUR 230 |
Human papillomavirus 42 |
PCR-H471-PCRH47196D |
Bioingentech |
PCR-H471-96D |
EUR 312 |
Human papillomavirus 43 |
PCR-H472-PCRH47248D |
Bioingentech |
PCR-H472-48D |
EUR 230 |
Human papillomavirus 43 |
PCR-H472-PCRH47296D |
Bioingentech |
PCR-H472-96D |
EUR 312 |
Human papillomavirus 44 |
PCR-H473-PCRH47348D |
Bioingentech |
PCR-H473-48D |
EUR 230 |
Human papillomavirus 44 |
PCR-H473-PCRH47396D |
Bioingentech |
PCR-H473-96D |
EUR 312 |
Human papillomavirus 45 |
PCR-H474-PCRH47448D |
Bioingentech |
PCR-H474-48D |
EUR 230 |
Human papillomavirus 45 |
PCR-H474-PCRH47496D |
Bioingentech |
PCR-H474-96D |
EUR 312 |
Human papillomavirus 51 |
PCR-H475-PCRH47548D |
Bioingentech |
PCR-H475-48D |
EUR 230 |
Human papillomavirus 51 |
PCR-H475-PCRH47596D |
Bioingentech |
PCR-H475-96D |
EUR 312 |
Human papillomavirus 52 |
PCR-H476-PCRH47648D |
Bioingentech |
PCR-H476-48D |
EUR 230 |
Human papillomavirus 52 |
PCR-H476-PCRH47696D |
Bioingentech |
PCR-H476-96D |
EUR 312 |
Human papillomavirus 56 |
PCR-H477-PCRH47748D |
Bioingentech |
PCR-H477-48D |
EUR 230 |
Human papillomavirus 56 |
PCR-H477-PCRH47796D |
Bioingentech |
PCR-H477-96D |
EUR 312 |
Human papillomavirus 58 |
PCR-H478-PCRH47848D |
Bioingentech |
PCR-H478-48D |
EUR 230 |
Human papillomavirus 58 |
PCR-H478-PCRH47896D |
Bioingentech |
PCR-H478-96D |
EUR 312 |
Human papillomavirus 59 |
PCR-H479-PCRH47948D |
Bioingentech |
PCR-H479-48D |
EUR 230 |
Human papillomavirus 59 |
PCR-H479-PCRH47996D |
Bioingentech |
PCR-H479-96D |
EUR 312 |
Human papillomavirus 6 |
Oneq-H461-OneqH461100D |
Bioingentech |
Oneq-H461-100D |
EUR 515 |
Human papillomavirus 6 |
Oneq-H461-OneqH461150D |
Bioingentech |
Oneq-H461-150D |
EUR 594 |
Human papillomavirus 6 |
Oneq-H461-OneqH46150D |
Bioingentech |
Oneq-H461-50D |
EUR 413 |
Human papillomavirus 11 |
Oneq-H462-OneqH462100D |
Bioingentech |
Oneq-H462-100D |
EUR 515 |
Human papillomavirus 11 |
Oneq-H462-OneqH462150D |
Bioingentech |
Oneq-H462-150D |
EUR 594 |
Human papillomavirus 11 |
Oneq-H462-OneqH46250D |
Bioingentech |
Oneq-H462-50D |
EUR 413 |
Human papillomavirus 16 |
Oneq-H463-OneqH463100D |
Bioingentech |
Oneq-H463-100D |
EUR 515 |
Human papillomavirus 16 |
Oneq-H463-OneqH463150D |
Bioingentech |
Oneq-H463-150D |
EUR 594 |
Human papillomavirus 16 |
Oneq-H463-OneqH46350D |
Bioingentech |
Oneq-H463-50D |
EUR 413 |
Human papillomavirus 18 |
Oneq-H464-OneqH464100D |
Bioingentech |
Oneq-H464-100D |
EUR 515 |
Human papillomavirus 18 |
Oneq-H464-OneqH464150D |
Bioingentech |
Oneq-H464-150D |
EUR 594 |
Human papillomavirus 18 |
Oneq-H464-OneqH46450D |
Bioingentech |
Oneq-H464-50D |
EUR 413 |
Human papillomavirus 30 |
Oneq-H465-OneqH465100D |
Bioingentech |
Oneq-H465-100D |
EUR 515 |
Human papillomavirus 30 |
Oneq-H465-OneqH465150D |
Bioingentech |
Oneq-H465-150D |
EUR 594 |
Human papillomavirus 30 |
Oneq-H465-OneqH46550D |
Bioingentech |
Oneq-H465-50D |
EUR 413 |
Human papillomavirus 31 |
Oneq-H466-OneqH466100D |
Bioingentech |
Oneq-H466-100D |
EUR 515 |
Human papillomavirus 31 |
Oneq-H466-OneqH466150D |
Bioingentech |
Oneq-H466-150D |
EUR 594 |
Human papillomavirus 31 |
Oneq-H466-OneqH46650D |
Bioingentech |
Oneq-H466-50D |
EUR 413 |
Human papillomavirus 33 |
Oneq-H467-OneqH467100D |
Bioingentech |
Oneq-H467-100D |
EUR 515 |
Human papillomavirus 33 |
Oneq-H467-OneqH467150D |
Bioingentech |
Oneq-H467-150D |
EUR 594 |
Human papillomavirus 33 |
Oneq-H467-OneqH46750D |
Bioingentech |
Oneq-H467-50D |
EUR 413 |
Human papillomavirus 35 |
Oneq-H468-OneqH468100D |
Bioingentech |
Oneq-H468-100D |
EUR 515 |
Human papillomavirus 35 |
Oneq-H468-OneqH468150D |
Bioingentech |
Oneq-H468-150D |
EUR 594 |
Human papillomavirus 35 |
Oneq-H468-OneqH46850D |
Bioingentech |
Oneq-H468-50D |
EUR 413 |
Human papillomavirus 39 |
Oneq-H469-OneqH469100D |
Bioingentech |
Oneq-H469-100D |
EUR 515 |
Human papillomavirus 39 |
Oneq-H469-OneqH469150D |
Bioingentech |
Oneq-H469-150D |
EUR 594 |
First, the split-type ECL sensing platform can successfully keep away from interference from organic samples and adequately makes use of the ECL effectivity of the AuNC probe. Furthermore, the ultrahigh sensitivity assay of HPV DNA will be achieved with none complicated nucleic acid amplification method. Taking benefit of the above deserves of split-type detection, the ECL DNA sensor achieved ideally suited low detection of 6.eight aM and a large dynamic vary bridging 10 orders of magnitude HPV16 E7. Furthermore, along with its favorable and highly effective specificity, excessive sensitivity, and good selectivity, this technique might detect HPV16 E7 DNA in human samples, which confirmed nice consistency with the FDA-approved method (Hybrid seize 2, HC2).